Neurogene Stock (NASDAQ: NGNE) stock price, news, charts, stock research, profile.
Open | $29.890 |
Close | $29.960 |
Volume / Avg. | 47.839K / 138.355K |
Day Range | 29.880 - 31.520 |
52 Wk Range | 12.490 - 53.000 |
Market Cap | $385.075M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | - |
Days to Cover | 3.79 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Neurogene (NASDAQ: NGNE) through any online brokerage.
Other companies in Neurogene’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and PepGen (NASDAQ:PEPG).
The latest price target for Neurogene (NASDAQ: NGNE) was reported by William Blair on Thursday, March 21, 2024. The analyst firm set a price target for 0.00 expecting NGNE to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Neurogene (NASDAQ: NGNE) is $29.96 last updated April 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Neurogene.
Neurogene’s Q1 earnings are confirmed for Wednesday, May 15, 2024.
There is no upcoming split for Neurogene.
Neurogene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.